DK40385A - Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater - Google Patents
Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater Download PDFInfo
- Publication number
- DK40385A DK40385A DK40385A DK40385A DK40385A DK 40385 A DK40385 A DK 40385A DK 40385 A DK40385 A DK 40385A DK 40385 A DK40385 A DK 40385A DK 40385 A DK40385 A DK 40385A
- Authority
- DK
- Denmark
- Prior art keywords
- diguld
- omega
- bis
- hydrocarbon
- iii
- Prior art date
Links
- 239000004215 Carbon black (E152) Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 229930195733 hydrocarbon Natural products 0.000 title abstract 2
- 150000002430 hydrocarbons Chemical class 0.000 title abstract 2
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical class [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000004565 tumor cell growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5027—Polyphosphines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5045—Complexes or chelates of phosphines with metallic compounds or metals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57565084A | 1984-02-01 | 1984-02-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK40385D0 DK40385D0 (da) | 1985-01-29 |
DK40385A true DK40385A (da) | 1985-08-02 |
Family
ID=24301170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK40385A DK40385A (da) | 1984-02-01 | 1985-01-29 | Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0151046B1 (de) |
JP (1) | JPS60188322A (de) |
AT (1) | ATE43967T1 (de) |
AU (1) | AU572949B2 (de) |
CA (1) | CA1238854A (de) |
DE (1) | DE3570981D1 (de) |
DK (1) | DK40385A (de) |
IE (1) | IE850226L (de) |
ZA (1) | ZA85755B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1244764A (en) * | 1984-06-04 | 1988-11-15 | Randall K. Johnson | Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes |
US5037812A (en) * | 1985-04-02 | 1991-08-06 | Smithkline Beckman Corporation | Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes |
US4716230A (en) * | 1985-04-16 | 1987-12-29 | Smithkline Beckman Corporation | Certain bis(di-2 or 4-pyridyl-phosphino) alkanes #10 having anti-tumor properties |
DK166686A (da) * | 1985-04-16 | 1986-10-17 | Smithkline Beckman Corp | Phosphinforbindelser, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser |
US4902675A (en) * | 1985-05-16 | 1990-02-20 | Smithkline Beckman Corporation | "2-pyridyl and 4-pyridyl phosphine gold (I) anti tumor complexes" |
EP0202854A3 (de) * | 1985-05-20 | 1988-01-13 | Smithkline Beecham Corporation | Phosphin-Gold-Verbindungen |
US4698422A (en) * | 1985-05-20 | 1987-10-06 | Smithkline Beckman Corporation | Triphos and tetraphos gold compounds and ligands |
NL8502929A (nl) * | 1985-10-25 | 1987-05-18 | Tno | Groep viii-overgangsmetaal-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijke groep viii-overgangsmetaal-complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel. |
US4758589A (en) * | 1985-12-23 | 1988-07-19 | Smithkline Beckman Corporation | Tetraphosphine-coordinated gold(I) complexes |
US4764509A (en) * | 1986-02-21 | 1988-08-16 | Smithkline Beckman Corporation | Pharmaceutical compositions containing di-gold phosphine |
WO1995014703A1 (en) * | 1993-11-24 | 1995-06-01 | Luminis Pty. Ltd. | Triorganophosphinegold (i) thionucleobases with anti-tumor activity |
US6774254B2 (en) | 2000-04-10 | 2004-08-10 | National University Of Singapore | Gold complexes |
WO2001077121A1 (en) * | 2000-04-10 | 2001-10-18 | National University Of Singapore | Gold complexes |
DE10300097A1 (de) * | 2003-01-07 | 2004-07-22 | Bayer Ag | Kupfer-Komplexe und ihre Verwendung |
WO2009074305A1 (de) * | 2007-12-13 | 2009-06-18 | Biosphings Ag | Gold-xanthogenate und diese enthaltende arzneimittel |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3661959A (en) * | 1970-07-30 | 1972-05-09 | Du Pont | Method of making organogold chloride complexes |
US3676554A (en) * | 1970-10-30 | 1972-07-11 | Smith Kline French Lab | Anti-arthritic compositions comprising phosphine or phosphite gold halide complexes and methods of producing anti-arthritic activity |
CA1244764A (en) * | 1984-06-04 | 1988-11-15 | Randall K. Johnson | Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes |
-
1985
- 1985-01-07 CA CA000471598A patent/CA1238854A/en not_active Expired
- 1985-01-29 AU AU38126/85A patent/AU572949B2/en not_active Ceased
- 1985-01-29 DK DK40385A patent/DK40385A/da not_active Application Discontinuation
- 1985-01-31 DE DE8585300681T patent/DE3570981D1/de not_active Expired
- 1985-01-31 IE IE850226A patent/IE850226L/xx unknown
- 1985-01-31 AT AT85300681T patent/ATE43967T1/de not_active IP Right Cessation
- 1985-01-31 ZA ZA85755A patent/ZA85755B/xx unknown
- 1985-01-31 EP EP85300681A patent/EP0151046B1/de not_active Expired
- 1985-02-01 JP JP60019181A patent/JPS60188322A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU572949B2 (en) | 1988-05-19 |
EP0151046A2 (de) | 1985-08-07 |
AU3812685A (en) | 1985-08-29 |
IE850226L (en) | 1985-08-01 |
DE3570981D1 (en) | 1989-07-20 |
ZA85755B (en) | 1986-05-28 |
EP0151046B1 (de) | 1989-06-14 |
CA1238854A (en) | 1988-07-05 |
DK40385D0 (da) | 1985-01-29 |
JPS60188322A (ja) | 1985-09-25 |
EP0151046A3 (en) | 1985-08-21 |
ATE43967T1 (de) | 1989-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK40385D0 (da) | Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater | |
ES8207119A1 (es) | Procedimiento para preparar complejos de platino (iv)-diami-na. | |
DK0612248T3 (da) | Præparat, der indeholder cisplatin og topotecan som antitumormiddel | |
FI882380A0 (fi) | Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment. | |
JO1176B1 (en) | Organic platinum compound, method of preparation and use in the treatment of malignant tumors | |
ES2038724T3 (es) | Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas. | |
DE3376295D1 (en) | Pharmaceutical composition containing adenosine derivatives for use in treating tumours | |
SE8602743L (sv) | Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid | |
ATE216892T1 (de) | Inhibitor von nebenwirkungen zur krebstherapy | |
HU9401656D0 (en) | Pharmaceutical composition for treating tumours, containing creatine phosphate or phospho-enol-pyruvic acid | |
KR930700163A (ko) | 연조직 종양의 치료 및/또는 진단 방법 | |
ATE76579T1 (de) | Interferon-zusammensetzungen. | |
ES2134778T3 (es) | Bistriazenos como agentes quimioterapeuticos. | |
DE3776154D1 (de) | 1,2-diaminocyclohexan-platin-komplexe mit antitumor-wirkung. | |
PT100111A (pt) | Composicao para o tratamento de um mamifero sofrendo de doenca proliferativa dapele, benigna ou maligna, compreendendo um analogo de somatostatina | |
US4695449A (en) | Composition and method for treatment of melanomas | |
DK328088A (da) | Farmaceutisk komposition til behandling af tumorer | |
SE8103404L (sv) | Tennforeningar, sett att framstella dem, sett att framstella ett lekemedelspreparat under anvendning av en dylik tennforening for behandling av cancer samt det pa sa sett erhallna lekemedelspreparatet | |
GR880100589A (en) | Metalloporfyrines for the inversion of the toxic activity for the tumors treatment | |
ATE69551T1 (de) | Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren. | |
Ono et al. | The dose planning of BNCT for brain tumors | |
GB1352414A (en) | Histidine derivatives | |
ES2141114T3 (es) | Bistriazenos utilizados como agentes quimioterapeuticos. | |
ES8704181A1 (es) | Un procedimiento para preparar un compuesto de bis (difenilfosfino) alquil -bis-oro-i | |
ES456404A1 (es) | Un procedimiento para la preparacion de 4'-epi-6'hidroxia- dricina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |